Biology Reference
In-Depth Information
David, J., Shanbag, P., More, V., 2009.
Plasmodium vivax
malaria presenting as the nephrotic
syndrome in an infant. Trop. Doct 39 (2), 127-128.
Davis, J.S., et al., 2011. Sepsis in the tropical Top end of Australia's northern Territory: disease
burden and impact on indigenous Australians. Med. J. Aust. 194 (10), 519-524.
Day, N.P., et al., 1999. The prognostic and pathophysiologic role of pro- and antiinflamma-
tory cytokines in severe malaria. J. Infect. Dis. 180 (4), 1288-1297.
de Mast, Q., et al., 2008. ADAMTS13 deficiency with elevated levels of ultra-large and active
von Willebrand factor in malaria (abstract). Am. J. Trop. Med. Hyg. 79, s348.
de Mast, Q., et al., 2009. ADAMTS13 deficiency with elevated levels of ultra-large and active
von Willebrand factor in
P. falciparum
and
P. vivax
malaria. Am. J. Trop. Med. Hyg. 80 (3),
492-498.
Del Punta, V., et al., 2010. Congenital
Plasmodium vivax
malaria mimicking neonatal sepsis: a
case report. Malar. J. 9, 63.
Deplaine, G., et al., 2011. The sensing of poorly deformable red blood cells by the human
spleen can be mimicked in vitro. Blood 117 (8), e88-95.
Dhayagude, R.G., Purandare, N.M., 1943. Autopsy study of cerebral malaria with reference
to malarial granulomas. Arch. Pathol. 36, 550-558.
Dobson, M., 1997. Contours of Death and Disease in Early Modern England. Cambridge
University Press, , Cambridge.
Dondorp, A.M., et al., 1999. Red blood cell deformability as a predictor of anemia in severe
falciparum malaria. Am. J. Trop. Med. Hyg. 60 (5), 733-737.
Dondorp, A.M., et al., 2005. Estimation of the total parasite biomass in acute falciparum
malaria from plasma PfHRP2. PLoS Med. 2, e204.
Dondorp, A.M., et al., 2008. The relationship between age and the manifestations of and
mortality associated with severe malaria. Clin. Infect. Dis. 47 (2), 151-157.
Douglas, N.M., et al., 2010. Artemisinin combination therapy for vivax malaria. Lancet
Infect. Dis. 10, 405-416.
Douglas, N.M., et al., 2012. The anaemia of
Plasmodium vivax
malaria. Malar. J. 11 (1), 135.
el Hassan, A.M., et al., 1997. Decreased erythropoietin response in
Plasmodium falciparum
malaria-associated anaemia. Eur. J. Haematol. 59 (5), 299-304.
Eldridge, W., et al., 1925. Treatment of paresis: results of inoculation with the organism of
benign tertian malaria. J. Am. Med. Assoc. 84, 1097-1101.
Erel, O., et al., 1997. Oxidative stress and antioxidative status of plasma and erythrocytes in
patients with vivax malaria. Clin. Biochem. 30 (8), 631-639.
Ewing, J., 1901. Malarial parasitology. J. Exp. Med. 5, 429-491.
Falconer, A., 1919. The pulmonary manifestations in malaria. QJM 13, 25-34.
Fernando, S.D., et al., 2003a. The impact of repeated malaria attacks on the school perfor-
mance of children. Am. J. Trop. Med. Hyg. 69 (6), 582-588.
Fernando, D., de Silva, D., Wickremasinghe, R., 2003b. Short-term impact of an acute attack
of malaria on the cognitive performance of schoolchildren living in a malaria-endemic
area of Sri Lanka. Trans. R Soc. Trop. Med. Hyg. 97 (6), 633-639.
Field, J., Shute, P., 1956. Plasmodium vivax. The Microscopic Diagnosis of Human Malaria.
A Morphological Study of the Erythrocytic Parasites, vol. 2 Institute for Medical
Research, Kuala Lumpur.
Flower, B., et al., 2011. Blind, breathless, and paralysed from benign malaria. Lancet 377
(9763), 438.
Fong, T., 1937. A study of the mortality rate and complications following therapeutic malaria.
South. Med. J. 30, 1084-1088.
Fowkes, F.J., et al., 2008. Increased microerythrocyte count in homozygous alpha(+)-thal-
assaemia contributes to protection against severe malarial anaemia. PLoS Med. 5 (3), e56.
Franklin, B.S., et al., 2009. Malaria primes the innate immune response due to interferon-
gamma induced enhancement of toll-like receptor expression and function. Proc. Natl.
Acad. Sci. U S A 106 (14), 5789-5794.
